Integra LifeSciences Holdings Corporation (IART)
Market Cap | 986.95M |
Revenue (ttm) | 1.62B |
Net Income (ttm) | -28.96M |
Shares Out | 77.71M |
EPS (ttm) | -0.38 |
PE Ratio | n/a |
Forward PE | 5.40 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 417,693 |
Open | 12.77 |
Previous Close | 13.12 |
Day's Range | 12.69 - 12.77 |
52-Week Range | 11.60 - 32.66 |
Beta | 1.27 |
Analysts | Hold |
Price Target | 19.43 (+52.87%) |
Earnings Date | May 5, 2025 |
About IART
Integra LifeSciences Holdings Corporation manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamp... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 9 analysts, the average rating for IART stock is "Hold." The 12-month stock price forecast is $19.43, which is an increase of 52.87% from the latest price.
News

Integra LifeSciences Holdings Corporation (IART) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation ("Integra...

Bronstein, Gewirtz & Grossman, LLC Encourages Integra LifeSciences Holdings Corporation (IART) Shareholders to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESS Newswire / May 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation ("Integra...

Integra LifeSciences Holdings Corporation (IART) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / May 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation ("Integra...

Bronstein, Gewirtz & Grossman, LLC Is Investigating Integra LifeSciences Holdings Corporation (IART) And Encourages Investors to Connect
NEW YORK CITY, NY / ACCESS Newswire / May 25, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation ("Integra...

Bronstein, Gewirtz & Grossman, LLC Encourages Integra LifeSciences Holdings Corporation (IART) Stockholders to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESS Newswire / May 23, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation ("Integra...

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Integra LifeSciences Holdings Corporation (IART) and Encourages Investors to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / May 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation ("Integra...

Bronstein, Gewirtz & Grossman, LLC Is Investigating Integra LifeSciences Holdings Corporation (IART) And Encourages Stockholders to Connect
NEW YORK CITY, NY / ACCESS Newswire / May 21, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation ("Integra...

Integra LifeSciences Holdings Corporation (IART) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / May 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation ("Integra...

IART Investors Have Opportunity to Join Integra LifeSciences Holdings Corporation Fraud Investigation with the Schall Law Firm
LOS ANGELES , May 20, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Integra LifeSciences ...

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Integra LifeSciences Holdings Corporation (IART) and Encourages Stockholders to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / May 19, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation ("Integra...

Bronstein, Gewirtz & Grossman, LLC Encourages Integra LifeSciences Holdings Corporation (IART) Investors to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESS Newswire / May 18, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation ("Integra...

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Integra LifeSciences Holdings Corporation (IART) And Encourages Investors to Reach Out
NEW YORK CITY, NY / ACCESS Newswire / May 16, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation ("Integra...

Integra LifeSciences Holdings Corporation (IART) Q1 2025 Earnings Call Transcript
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q1 2025 Earnings Conference Call May 5, 2025 8:30 AM ET Company Participants Chris Ward - Senior Director, Investor Relations Mojdeh Poul - Pre...

Integra LifeSciences Reports First Quarter 2025 Financial Results
PRINCETON, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first ...

Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025
PRINCETON, N.J., April 18, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2025 financial res...

Notice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf
PHILADELPHIA, March 22, 2025 (GLOBE NEWSWIRE) -- Grabar Law Office is investigating whether the Board of Directors of Integra LifeSciences Holdings Corp. (NASDAQ: IART) breached their fiduciary duties...

Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
PRINCETON, N.J., March 13, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Mojdeh Poul, chief execu...

Integra LifeSciences: Light At The End Of The Tunnel, Or Another Oncoming Train? (Rating Upgrade)
Integra LifeSciences had a rough 2024 as the company's quality control remediation efforts had a bigger than expected negative impact on results. Q4 '24 offered some stability with organic revenue gro...

Integra LifeSciences Holdings Corporation (IART) Q4 2024 Earnings Call Transcript
Integra LifeSciences Holdings Corporation (IART) Q4 2024 Earnings Call Transcript

Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides 2025 Financial Guidance
PRINCETON, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 202...

Jan De Witte joins GHO Capital as Operating Partner
Jan De Witte joins GHO Capital as Operating Partner Former CEO of Integra LifeSciences with significant strategic and operational experience to support GHO Capital's portfolio London, UK – 11 February...

Notice To Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf
PHILADELPHIA, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Grabar Law Office is investigating whether the Board of Directors of Integra LifeSciences Holdings Corp. (NASDAQ: IART) breached their fiduciary duties ...

Integra LifeSciences to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on February 25, 2025
PRINCETON, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2024...

Integra LifeSciences Launches Integra Institute for Healthcare Professionals (HCPs)
New global medical education platform offers digital tools to keep HCPs at the forefront of medical knowledge New global medical education platform offers digital tools to keep HCPs at the forefront o...

Integra's DuraSeal® Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research
The health economic analysis, conducted in five European countries, shows that hospitals can reduce costs of cerebrospinal fluid leaks after posterior cranial fossa surgeries by using DuraSeal dural s...